Caveolin-3 protects diabetic hearts from acute myocardial infarction/reperfusion injury through β2AR, cAMP/PKA, and BDNF/TrkB signaling pathways.

Aging
Jiaji GongFeng Xiao

Abstract

Diabetes mellitus (DM) might increase the incidence and mortality of cardiac failure after acute myocardial infarction (AMI) in patients. We attempted to investigate whether Caveolin-3 showed beneficial effects in DM patient post-MI injury through the cAMP/PKA and BDNF/TrkB signaling pathways. The activity of ADRB2 and cAMP/PKA signaling were impaired in nondiabetic ischemia-reperfusion (I/R) group compared with the sham and DM groups and were more impaired in diabetic I/R group than in the I/R group. In H9C2 cells, high-glucose (HG) stimulation further enhanced H/R injury by promoting cell apoptosis, inhibiting cell viability, and suppressing TrkB and Akt signaling; in contrast, the ADRB2 agonist isoprenaline (ISO) significantly attenuated the above-described effects of HG stimulation. Caveolin-3 overexpression promoted the localization of ADRB2 on the membrane of the HG-stimulated H9C2 cells, subsequently inhibiting apoptosis and promoting cell viability. Under HG stimulation, Caveolin-3 overexpression enhanced the activity of the cAMP/PKA and BDNF/TrkB signaling pathways, whereas ADRB2 silencing reversed the effects of Caveolin-3 overexpression. In conclusion, ADRB2 agonist promoted the activity of the BDNF/TrkB and cAMP/PKA...Continue Reading

References

Nov 15, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·L E Otterbein, A M Choi
Jul 6, 2004·Molecular and Cellular Neurosciences·Rubén DeograciasAngeles Rodríguez-Peña
Oct 20, 2004·Cardiovascular Drug Reviews·Candi Nobles-JamesJames R Sowers
Jun 28, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K SrinivasanP Ramarao
Sep 26, 2007·American Heart Journal·Jorge R AlegriaUNKNOWN Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators
Jun 3, 2008·Journal of Molecular and Cellular Cardiology·Sarah CalaghanEd White
Dec 18, 2009·Histology and Histopathology·Tadahiro NumakawaHiroshi Kunugi
Apr 3, 2010·Circulation Research·Marco MeloniCostanza Emanueli
Mar 14, 2012·Advances in Experimental Medicine and Biology·Mathivadhani PanneerselvamDavid M Roth
Apr 10, 2013·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Kathleen E DennisMichael F Hill
Jun 20, 2013·Cardiovascular Diabetology·Hong LiChuanshi Xiao
Dec 19, 2013·Journal of Molecular and Cellular Cardiology·Peter T WrightJulia Gorelik
Jan 17, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael J Van KaneganDonald C Lo
Sep 10, 2014·Cardiovascular Diabetology·Yasuo M TsutsumiKatsuya Tanaka
Dec 9, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Zhenwei ShiHaifeng Zhang
Apr 22, 2015·International Journal of Biological Sciences·Pengzhou HangZhimin Du
Oct 16, 2015·The Journal of Biological Chemistry·Lee B Bockus, Kenneth M Humphries
Oct 23, 2015·Cardiovascular Diabetology·Mingge DingXiaoming Wang
Aug 5, 2016·International Journal of Biological Sciences·Pengzhou HangZhimin Du
Nov 5, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Simon M BryantAndrew F James
May 29, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Limin HuangHui Chen
Nov 23, 2018·Journal of Experimental & Clinical Cancer Research : CR·Hua LiuYu Liang

❮ Previous
Next ❯

Methods Mentioned

BETA
chip
coronary artery ligation
PCR
ELISA
Flow cytometry
transfection

Software Mentioned

SPSS

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.